Waste Management, Inc. (NYSE:WM) shares decreased -1.33% in last trading session and ended the day at $51.92. WM Gross Margin is 44.30% and its has a return on assets of 5.20%. Waste Management, Inc. (NYSE:WM) quarterly performance is -0.41%.
Waste Management, Inc. (NYSE:WM) announced that it will release fourth quarter and full-year 2015 financial results before the opening of the market on Thursday, February 18, 2016. Following the release, Waste Management will host its investor conference call at 10:00 a.m. ET.
Bristow Group, Inc. (NYSE:BRS) ended the last trading day at $18.45. Company weekly volatility is calculated as 10.16% and price to cash ratio as 4.63. Bristow Group, Inc. (NYSE:BRS) showed a weekly performance of -12.31%.
Bristow Group Inc. (NYSE:BRS), the leading provider of helicopter services to the offshore energy industry, announced it will release financial results for its fiscal year 2016 third quarter ended December 31, 2015, after the market closes on Monday, February 8, 2016.
On 20 January, Praxair Inc. (NYSE:PX) shares decreased -0.37% and was closed at $97.82. PX EPS growth in last 5 year was 7.40%. Praxair Inc. (NYSE:PX) year to date (YTD) performance is -4.47%.
Praxair, Inc. (NYSE:PX) will release its fourth quarter 2015 financial results on January 29, 2016, before the market opens and will host a conference call at 11:00 a.m. ET that morning. Following are details for the listen-only conference call, which will be available live and on demand to the public and the media.
Cytosorbents Corporation (NASDAQ:CTSO) shares increased 2.48% in last trading session and ended the day at $4.13. CTSO Gross Margin is 56.40% and its has a return on assets of -129.40%. Cytosorbents Corporation (NASDAQ:CTSO) quarterly performance is -34.13%.
On 11 January, it was reported CytoSorbents Corporation (NASDAQ:CTSO), a critical care immunotherapy company commercializing its European Union approved CytoSorb® blood filter to treat deadly inflammation in critically-ill and cardiac surgery patients worldwide, issues a letter to its stockholders from Chief Executive Officer, Dr. Phillip Chan.
Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX) caters to the Healthcare space. It has a net profit margin of -40.60% and weekly performance is -27.89%. On the last day of trading company shares ended up at $1.81. Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX) distance from 50-day simple moving average (SMA50) is -22.47%.
The Law Offices of Vincent Wong are investigating potential claims against the Board of Directors of Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX) in connection with possible breaches of fiduciary duty.